Listed bio company's first quarter sales were KRW 9.5 trillion... 16% increase
⚡ Quick Summary
(Seoul = Yonhap News) Reporter Park Sang-hyun = Both sales and exports of major domestic listed bio healthcare companies in the first quarter of this year were found to have increased significantly.